Search alternatives:
point decrease » point increase (Expand Search)
men decrease » nn decrease (Expand Search), we decrease (Expand Search), meja decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a men » a mean (Expand Search), _ men (Expand Search)
point decrease » point increase (Expand Search)
men decrease » nn decrease (Expand Search), we decrease (Expand Search), meja decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a men » a mean (Expand Search), _ men (Expand Search)
-
1021
-
1022
Retinoschisin secretion into the conditioned medium is decreased by addition of jasplakinolide.
Published 2013“…As seen, retinoschisin secretion into the conditioned medium is decreased by 1 uM jasplakinolide. (C) Quantification of the intensity of each band in the Western blot in (B) (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0020707#s4" target="_blank">MATERIALS AND METHODS</a>). …”
-
1023
-
1024
-
1025
-
1026
-
1027
CONSORT flowchart for the study.
Published 2024“…Mean (standard deviation) patient satisfaction was 11.78 (4.65) in the intervention group and 9.04 (2.95) in the control group; the independent t-test revealed a significant difference between the two groups (P<0.001).…”
-
1028
Participants’ demographic characteristics.
Published 2024“…Mean (standard deviation) patient satisfaction was 11.78 (4.65) in the intervention group and 9.04 (2.95) in the control group; the independent t-test revealed a significant difference between the two groups (P<0.001).…”
-
1029
-
1030
Nilotinib decreases viability and proliferation of HEI-193 cells in a dose-dependent manner.
Published 2013“…Shown, mean value of six technical replicates. *denotes significant value (<i>p</i><0.05), **denotes significant value (p<0.005) (A) Nilotinib decreased absorbance on MTS viability assay in both growth conditions. …”
-
1031
-
1032
-
1033
-
1034
-
1035
-
1036
-
1037
-
1038
-
1039
-
1040